May 19, 2025 · Form 4 insider transaction
Renninger Robert bought 10,000 shares of Athira Pharma, Inc. at $0.23 per share, a transaction worth $2.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 44 days after the transaction.
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"),for the ESPP Purchase Period (as defined in the ESPP) of November 18, 2024 through May 19, 2025. This transaction is exempt under Rule 16b-3(c).; The Purchase Period ended March 19, 2025 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began November 18, 2024.; In accordance with the ESPP, these shares were purchased based on 85% of the closing price on May 19, 2025.